Patients with Encapsulating Peritoneal Sclerosis Have Increased Peritoneal Expression of Connective Tissue Growth Factor (CCN2), Transforming Growth Factor-β1, and Vascular Endothelial Growth Factor

INTRODUCTION: Encapsulating peritoneal sclerosis (EPS) is a devastating complication of peritoneal dialysis (PD). The pathogenesis is not exactly known and no preventive strategy or targeted medical therapy is available. CCN2 has both pro-fibrotic and pro-angiogenic actions and appears an attractive...

Descripción completa

Detalles Bibliográficos
Autores principales: Abrahams, Alferso C., Habib, Sayed M., Dendooven, Amélie, Riser, Bruce L., van der Veer, Jan Willem, Toorop, Raechel J., Betjes, Michiel G. H., Verhaar, Marianne C., Watson, Christopher J. E., Nguyen, Tri Q., Boer, Walther H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226475/
https://www.ncbi.nlm.nih.gov/pubmed/25384022
http://dx.doi.org/10.1371/journal.pone.0112050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226475/
https://www.ncbi.nlm.nih.gov/pubmed/25384022
http://dx.doi.org/10.1371/journal.pone.0112050

Ejemplares similares